2017 | Unshielding Exosomal RNA Unleashes Tumor Growth And Metastasis
| CELL |
2015 | Untreated Congenital Adrenal Hyperplasia with 17-α Hydroxylase/17, 20-lyase Deficiency Presenting as Massive Adrenocortical Tumor
| Endocrinology and Metabolism (대한내분비학회지) |
2019 | Unusual Case of Recurrent Pericardial Effusion - Erdheim-Chester Disease
| CIRCULATION JOURNAL |
2020 | Unusual metastases from differentiated thyroid cancers: A multicenter study in Korea
| PLOS ONE |
2023 | Unveiling and harnessing the human gut microbiome in the rising burden of non-communicable diseases during urbanization
| GUT MICROBES |
2023 | Unveiling the anode reaction environment in a CO2 electrolyzer to provide a guideline for anode development | JOURNAL OF MATERIALS CHEMISTRY A |
2007 | Up-regulated claudin 7 expression in intestinal-type gastric carcinoma | ONCOLOGY REPORTS |
2014 | Up-regulation of fibroblast growth factor (FGF) 9 expression and FGF-WNT/β-catenin signaling in laser-induced wound healing | WOUND REPAIR AND REGENERATION |
2011 | Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor Atorvastatin and hepatic LRP1 expression | METABOLISM-CLINICAL AND EXPERIMENTAL |
2023 | Up-to-Date Clinical Practice in Percutaneous Coronary Intervention for Multivessel Disease
| JACC: Asia |
2022 | Update from the ongoing phase 1/2 registrational trial of repotrectinib: results in TKI-naïve and TKI-pretreated patients with NTRK fusion-positive advanced solid tumors (TRIDENT-1) | EUROPEAN JOURNAL OF CANCER |
2017 | Update on Familial Hypercholesterolemia: Diagnosis, Cardiovascular Risk, and Novel Therapeutics
| Endocrinology and Metabolism (대한내분비학회지) |
2015 | Update on Pancreatobiliary Stents: Stent Placement in Advanced Hilar Tumors
| CLINICAL ENDOSCOPY |
2022 | Update on Preoperative Parathyroid Localization in Primary Hyperparathyroidism
| Endocrinology and Metabolism(대한내분비학회지) |
2022 | Update on the POEMS syndrome
| BLOOD RESEARCH |
2020 | Update on the Treatment of Behcet's Disease of the Small Bowel with Biologic Agents | Current Gastroenterology Reports |
2022 | Updated analyses from the CROWN study of first-line lorlatinib vs crizotinib in Asian patients with ALK-positive non-small cell lung cancer (NSCLC) | ANNALS OF ONCOLOGY |
2022 | Updated ARROW data: Pralsetinib in patients (pts) with advanced or metastatic RET-altered thyroid cancer (TC) | ANNALS OF ONCOLOGY |
2019 | Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study
| Journal of Thoracic Oncology |
2024 | Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer
| LUNG CANCER |